Insider Buying: FMC (NYSE:FMC) Director Acquires 7,000 Shares of Stock

FMC Corporation (NYSE:FMC) Director John Mitchell Raines acquired 7,000 shares of the business’s stock in a transaction that occurred on Thursday, November 13th. The shares were purchased at an average cost of $13.77 per share, for a total transaction of $96,390.00. Following the acquisition, the director owned 13,784 shares in the company, valued at $189,805.68. This represents a 103.18% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

FMC Trading Up 0.7%

FMC stock traded up $0.09 during trading hours on Friday, hitting $13.73. The stock had a trading volume of 615,125 shares, compared to its average volume of 2,918,298. The business’s 50 day simple moving average is $28.80 and its 200-day simple moving average is $36.30. FMC Corporation has a one year low of $12.87 and a one year high of $61.26. The stock has a market cap of $1.72 billion, a price-to-earnings ratio of 17.16, a P/E/G ratio of 1.09 and a beta of 0.72. The company has a quick ratio of 1.14, a current ratio of 1.53 and a debt-to-equity ratio of 0.74.

FMC (NYSE:FMC) last posted its quarterly earnings data on Wednesday, October 29th. The basic materials company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.04. FMC had a return on equity of 9.36% and a net margin of 2.42%.The business had revenue of $542.20 million during the quarter, compared to the consensus estimate of $1.08 billion. During the same period in the prior year, the business posted $0.69 earnings per share. FMC’s quarterly revenue was down 49.1% on a year-over-year basis. FMC has set its Q4 2025 guidance at 1.140-1.360 EPS. FY 2025 guidance at 2.920-3.140 EPS. On average, equities analysts predict that FMC Corporation will post 3.48 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on FMC. UBS Group dropped their target price on shares of FMC from $36.00 to $17.00 and set a “neutral” rating on the stock in a research report on Friday, October 31st. Morgan Stanley dropped their price target on FMC from $38.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Monday, November 3rd. KeyCorp reiterated a “sector weight” rating on shares of FMC in a report on Friday, October 31st. Wells Fargo & Company assumed coverage on FMC in a research report on Tuesday. They set an “equal weight” rating and a $16.00 target price for the company. Finally, Citigroup reduced their price target on shares of FMC from $34.00 to $17.00 and set a “neutral” rating for the company in a research report on Friday, October 31st. Three research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $29.25.

Institutional Trading of FMC

A number of hedge funds have recently bought and sold shares of FMC. Financial Harvest LLC bought a new position in shares of FMC in the first quarter worth approximately $29,000. Elequin Capital LP bought a new position in shares of FMC during the first quarter valued at $30,000. Creative Financial Designs Inc. ADV grew its position in FMC by 180.1% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 815 shares of the basic materials company’s stock valued at $34,000 after purchasing an additional 524 shares during the last quarter. AlphaQuest LLC purchased a new position in FMC in the first quarter worth about $74,000. Finally, Brooklyn Investment Group lifted its position in FMC by 403.1% in the 1st quarter. Brooklyn Investment Group now owns 2,465 shares of the basic materials company’s stock valued at $104,000 after acquiring an additional 1,975 shares in the last quarter. Institutional investors own 91.86% of the company’s stock.

About FMC

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control.